Related Experiment Videos
Antiendotoxin monoclonal antibodies for gram-negative sepsis
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Imipenem resistance in Enterobacter.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·1993
Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis.
American journal of critical care : an official publication, American Association of Critical-Care Nurses·1993
Blastomycosis in patients with the acquired immunodeficiency syndrome.
Annals of internal medicine·1992
The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
Infectious disease clinics of North America·1991
A Multistate Investigation of Serious Adverse Events, including Deaths, following Ceftriaxone Injections, September 2024-August 2025.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
From bedside to broadband: Evaluating outcomes of telehealth infectious diseases consultations.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Cefepime versus piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa pneumonia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Direct Initiation of Long-Acting Cabotegravir Plus Rilpivirine in People with HIV and Suboptimal Virologic Suppression: A Randomized Trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Retrospective Cohort Study Assessing Remdesivir Effectiveness in Hospitalized COVID-19 Patients With Renal or Hepatic Comorbidities.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Financial Impact of a Long-Acting Injectable Cabotegravir/Rilpivirine Program: A Real-World Experience.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Reversing Dysfunction of CCR9+ Regulatory T Cells by Targeting the IL-21/IL-17 Axis Improves Type 1 Diabetes.
Diabetes, metabolic syndrome and obesity : targets and therapy·2026
The Patient With Multiple Alloantibodies: A Systematic Strategy for Antibody Identification and Transfusion Management.
Case reports in immunology·2026